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The role of autophagy in retinal ganglion cell (RGC) death is still controversial. Several studies focused on
RGC body death, although the axonal degeneration pathway in the optic nerve has not been well
documented in spite of evidence that the mechanisms of degeneration of neuronal cell bodies and their
axons differ. Axonal degeneration of RGCs is a hallmark of glaucoma, and a pattern of localized retinal
nerve ﬁber layer defects in glaucoma patients indicates that axonal degeneration may precede RGC body
death in this condition. As models of preceding axonal degeneration, both the tumor necrosis factor
(TNF) injection model and hypertensive glaucoma model may be useful in understanding the mechanism
of axonal degeneration of RGCs, and the concept of axonal protection can be an attractive approach to the
prevention of neurodegenerative optic nerve disease. Since mitochondria play crucial roles in glau-
comatous optic neuropathy and can themselves serve as a part of the autophagosome, it seems that
mitochondrial function may alter autophagy machinery. Like other neurodegenerative diseases, optic
nerve degeneration may exhibit autophagic ﬂux impairment resulting from elevated intraocular pres-
sure, TNF, traumatic injury, ischemia, oxidative stress, and aging. As a model of aging, we used
senescence-accelerated mice to provide new insights. In this review, we attempt to describe the rela-
tionship between autophagy and recently reported noteworthy factors including Nmnat, ROCK, and
SIRT1 in the degeneration of RGCs and their axons and propose possible mechanisms of axonal pro-
tection via modulation of autophagy machinery.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Autophagy, or cellular self-digestion, is a cellular pathway
involved in protein and organelle degradation and has been asso-
ciated with a cell-protective process and conversely linked to a role
in cell death (Mizushima et al., 2008). Among the three types of
autophagy (macroautophagy, microautophagy, and chaperone-
mediated autophagy), macroautophagy (referred to as autophagy
hereafter) is mediated by a unique organelle called the autopha-
gosome, which is characterized by the formation of a double-
membraned structure (Mizushima, 2007). The most typical
inducer of autophagy is nutrient starvation. Under starvation or
after rapamycin treatment, the numbers of all autophagic struc-
tures including isolation membranes, autophagosomes, and auto-
lysosomes are increased and autophagic ﬂux is also increased
compared with the basal levels (Mizushima et al., 2010). Impor-
tantly, the number of autophagosomes increases when steps in the
autophagy pathway downstream of autophagosome formation are
blockaded (Mizushima et al., 2010), indicating that the increase in
autophagosomes does not always result in autophagic activation.
Several autophagy-related (Atg) genes have been identiﬁed in
yeast and many of these have been conﬁrmed to be mammalian
orthologues. Beclin 1/Atg6 was shown to play a central role in
autophagy, and sufﬁcient levels of Beclin 1 are necessary for its
autophagic function (Wirawan et al., 2012). It regulates autopha-
gosome formation as a Beclin 1 complex (Wirawan et al., 2012).
Among several Atg proteins, microtubule-associated protein light
chain 3 (LC3)/Atg8 is known to occur on autophagosomes and is
used as their marker (Kabeya et al., 2000). LC3 is speciﬁcally
localized to the phagofore, the autophagosome, and the autolyso-
some. LC3-I is the cytosolic form, and LC3-II is associated with
autophagosome membranes. Mammalian Atg4 homologues are
cysteine proteases required for the autophagy process, which
cleave the C-terminal peptide of LC3 (Mari~no et al., 2003; Kabeya
et al., 2004) to produce LC3-I, which resides in the cytosol
(Kabeya et al., 2000). LC3-I is conjugated to phosphatidylethanol-
amine in a reaction involving Atg7 and Atg3 to form LC3-II (Kabeya
et al., 2000). The amount of LC3-II correlates closely with auto-
phagosome number (Mizushima et al., 2010). However, the above
ﬁnding that the increase in autophagosomes does not always result
in autophagic activation means that the focus should be on inter-
preting the meaning of the amounts of LC3-II present in the auto-
phagosomes. That is, an increase in the LC3-II level as shown by
immunoblotting indicates either autophagy induction or the sup-
pression of a downstream step in autophagy.To distinguish between autophagy induction and the sup-
pression of a downstream step in autophagy, the measurement of
autophagic ﬂux, which refers to the entire process of autophagy,
including autophagosome formation, maturation, and fusion with
lysosomes, is useful; it is generally higher in the former condition
and lower in the latter. One method for detecting autophagic ﬂux
is estimating LC3 immunoblotting with or without lysosomal in-
hibitors (Mizushima and Yoshimori, 2007). According to a review
article, lysosomal protease inhibitors can partially inhibit the
degradation of LC3-II, whereas they do not affect the degradation
of LC3-I, thereby indicating that the amount of LC3-II at a certain
time point does not indicate total autophagic ﬂux and that
autophagic ﬂux is more accurately represented by differences in
the amount of LC3-II between samples in the presence and
absence of lysosomal protease inhibitors (Mizushima and
Yoshimori, 2007). It is important to note that some antibodies
against LC3 react preferentially with the LC3-II form rather than
the LC3-I form, and therefore the signal ratio between LC3-I and
LC3-II provides little information (Kimura et al., 2009). Another
method for detecting autophagic ﬂux is measuring levels of p62,
which is also called sequestosome 1 (SQSTM1) (Bjørkøy et al.,
2005). It was demonstrated that LC3 colocalized with p62, and
that these two proteins participated in the same complexes
(Bjørkøy et al., 2005). p62 is normally degraded by the lysosomal
proteases through the interaction with LC3-II (Ichimura and
Komatsu, 2010). Since p62 accumulates when autophagy is
inhibited, and decreased levels can be observed when autophagy
is induced, p62 may be used as a marker of autophagic ﬂux
(Bjørkøy et al., 2009). For example, Atg4-deﬁcient mice reach
adulthood with no excess mortality, are fertile, and do not present
any obvious histopathological or biochemical alteration (Mari~no
et al., 2010). These mice are useful for autophagy research
because they display a substantial systemic reduction in auto-
phagic activity and reduced basal autophagic ﬂux (Mari~no et al.,
2010). In that study, p62 protein levels were decreased after
starvation in control mice and also decreased after starvation in
Atg4-deﬁcient mice skeletal muscle and liver. However, the p62
protein levels were always higher in the mutant mice tissue than
in that from WT mice subjected to the same starvation conditions
(Mari~no et al., 2010), indicating an impairment of autophagic
activity in these mutant mice. Therefore, p62 protein levels can
reﬂect relatively accurately the degree of autophagic conditions in
several tissue types. Thus, the examination of both LC3-II and p62
protein levels is important for understanding the status of auto-
phagic activity.
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2.1. Optic nerve transection
LC3 immunohistochemistry is predominantly expressed in the
retinal ganglion cell (RGC) layer and in photoreceptors (Kim et al.,
2008). The LC3-II protein level as shown by immunoblotting in
isolated RGCs was signiﬁcantly upregulated 1 day to 1 week, with
the peak at 3 days, after optic nerve transection (Kim et al., 2008),
implying a possible activation of autophagy in RGCs in optic nerve
damage. This ﬁnding has been supported by a recent study
demonstrating that autophagosomes were signiﬁcantly increased
in RGCs 3e10 days after optic nerve transection (Rodríguez-Muela
et al., 2012). Rapamycin, an inducer of autophagy, signiﬁcantly
increased the number of Brn-3a-immunopositive RGCs compared
with those in vehicle-treated mice 10 days after optic nerve tran-
section (Rodríguez-Muela et al., 2012). Interestingly, p62 protein
levels in the retina were higher in Atg4-deﬁcient mice, which show
reduced basal autophagic ﬂux comparedwithWTmice (Rodríguez-
Muela et al., 2012). Moreover, LC3-II levels in the retina were lower
in Atg4-deﬁcient mice compared with WT mice, indicating the
reduction of autophagic activity in the mutant retina (Rodríguez-
Muela et al., 2012). Furthermore, that study demonstrated a
reduced number of surviving RGCs in Atg4-deﬁcient mice after
optic nerve transection compared with those in WT mice. These
ﬁndings suggest that the activation of autophagy exerts a protective
role on RGCs after traumatic optic nerve injury.
2.2. Ocular hypertension
Acute intraocular pressure (IOP) elevation (approximately
110 mmHg) is used for the retinal ischemiaereperfusion model in
rats, and the ocular hypertension model usually means chronic
mild IOP elevation (approximately 30e40 mmHg). Three general
models have been described: 1) hypertonic saline injection to the
aqueous humor outﬂow pathway; 2) limbal laser treatment; and 3)
episcleral vein cautery (Morrison et al., 2005). Among them, the
vein cautery model may produce less injury than the other two
models, because the congestions of the choroidal vasculature, of
veins surrounding the optic nerve head, or of the vasculature of the
adjacent sclera may affect the nerve ﬁbers (Morrison et al., 2005).
Thus, these models may not all be equal, and caution should be
used in interpreting the autophagic ﬁndings in these models. In the
chronic hypertensive rat model with episcleral vein cautery, it was
shown that autophagosomes were increased in the RGC layer 1e4
weeks after IOP elevation (Park et al., 2012). Similarly, LC3-II levels
in the retina were increased 1e4 weeks after IOP elevation. It is
reasonable to speculate that those LC3-II levels in the retina reﬂect
mainly autophagosomes in RGC bodies rather than autophago-
somes in dendrites in the inner plexiform layer (IPL) because
increased autophagosomes in the IPL were observed 1 and 2 weeks
after IOP elevation but not at 4 weeks (Park et al., 2012). In pri-
mates, long periods (e.g., 40 weeks) of IOP elevation leads to optic
disc cupping. A recent study has demonstrated increases in LC3-II
levels in the retina in similar long-term periods of IOP elevation
in a rhesus monkey glaucoma model (Deng et al., 2013). Even after
such long periods, increased immunoreactivity of LC3B was
observed in the RGC layer and IPL compared with that in normal
controls (Deng et al., 2013). Therefore, it is possible that increased
autophagosomes in RGCs may occur in glaucoma patients. How-
ever, it is puzzling to interpret the role of autophagy in RGC death
because of the controversial results showing that 3-methyladenine
(3-MA), an autophagy inhibitor, is protective whereas rapamycin,
an autophagic inducer, is also protective in the same hypertensive
experimental glaucoma rat model (Park et al., 2012; Su et al., 2014).Another aspect is that tumor necrosis factor (TNF) was found to be
increased in the mouse retina after IOP elevation (Nakazawa et al.,
2006), and that upregulated TNF was signiﬁcantly inhibited by
rapamycin with its protective effect on RGC bodies in hypertensive
glaucoma rats (Su et al., 2014).
2.3. Ischemia
In the retinal ischemiaereperfusion model, a previous study
showed that LC3-II levels were signiﬁcantly decreased at the end of
ischemia (reperfusion 0 h) and maintained at below basal levels in
the retina during the ﬁrst hour of reperfusion (Russo et al., 2011),
although the possibility that under these circumstance all protein
syntheses and cellular activity that require energy are severely
compromised cannot be excluded. That study suggested the
impairment of autophagy in the ischemic retina and a neuro-
protective role of autophagy in RGCs (Russo et al., 2011). In the
study by Russo et al. (2011), there was no difference in LC3-II levels
at 24 h between the nonischemic control and ischemic retina
groups. However, another study found an increase in the LC3-II
level in the retina 24 h after ischemiaereperfusion compared
with controls (Piras et al., 2011). Although it is difﬁcult to explain
this difference, one hypothesis is that LC3-II levels may decrease in
the early phase and return to the basal level or increase more at
around 24 h after ischemic injury. In view of the role of autophagy,
that study showed that the decrease in cell number in the RGC layer
induced by ischemia was partially attenuated by 3-MA, an auto-
phagy inhibitor, and that the positivity for apoptotic markers was
suppressed by 3-MA, suggesting that autophagy and apoptosis can
coexist in the same damaged neurons after ischemiaereperfusion
(Piras et al., 2011). In accordance with this observation, post-
ischemic induction of autophagy by intravitreal rapamycin
administration did not provide protection against lesions induced
by ischemic stress in the retina (Produit-Zengafﬁnen et al., 2014).
2.4. RGC-5 cells
It has been documented that RGC-5 cells are not derived from
immortalized rat RGCs but represent a lineage of mouse neuronal
precursor cells (Van Bergen et al., 2009). Recently, it has been
shown that RGC-5 cells are not of RGC origin, but are the cell line
661W, a mouse SV-40 T antigen-transformed photoreceptor cell
line (Krishnamoorthy et al., 2013). Therefore, one must be careful in
interpreting the ﬁndings of several studies in RGC-5 cells, i.e., one
can interpret the ﬁndings in RGC-5 cells as an in vitro model for
retinal neuronal cells. Using this in vitro system, several studies
demonstrated the autophagic machinery under starvation or some
forms of stress. For example, serum deprivation resulted in
increased LC3 distribution in autophagosomes in RGC-5 cells (Kim
et al., 2008). Three different autophagy inhibitors, baﬁlomycin A1
(BafA1), 3-MA, and wortmannin, reduced cell viability under star-
vation conditions in RGC-5 cells (Kim et al., 2008). Other reports
showed that serum deprivation resulted in increased LC3-II levels
in RGC-5 cells along with reduced RGC-5 cell survival (Russo et al.,
2011). That study also showed that BafA1 and 3-MA reduced cell
viability in starved RGC-5 cells (Russo et al., 2011). Since BafA1
prevents the maturation of autophagic vacuoles by inhibiting
fusion between autophagosomes and lysosomes (Yamamoto et al.,
1998), it is reasonable to ﬁnd the accumulation of LC3-I and -II in
RGC-5 cells treated with BafA1 in the presence or absence of serum
(Russo et al., 2011). The cumulative results suggest a protective role
of autophagy in RGC-5 cells under starvation conditions. It is also
interesting to note that rapamycin decreased intracellular reactive
oxygen species (ROS) production and increased cell viability and
that 3-MA increased ROS production and decreased cell viability in
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that treatment with the ROS-inducing agent paraquat induced an
increase in p62 levels in RGC-5 cells (Rodríguez-Muela et al., 2012),
which is consistent with a previous ﬁnding that the upregulation of
p62 protein was observed under oxidative stress (Jain et al., 2010).
Another study demonstrated that a portion of p62 directly localizes
within the mitochondria and supports the integrity of mitochon-
drial functions in other tissues (Lee and Shin, 2011). Consistent with
those ﬁndings, some p62-immunopositive dots were colocalized
with MitoTracker Red in nonstarved RGC-5 cells, and this colocal-
ization was more prominent in starved RGC-5 cells, indicating that
p62 was present in mitochondria (Fig. 1). Since it was shown that
rapamycin inhibited the increase in p62 levels induced by ROS in
RGC-5 cells (Rodríguez-Muela et al., 2012), it is plausible that the
activation of autophagy may exert protective effects with the in-
hibition of p62. The detailed relationship between mitochondrial
function and p62 in the protective effect of rapamycin needs to be
examined at the subcellular fraction level in immunoblotting and
double immunoﬂuorescence studies.
3. Autophagy in optic nerve axons
3.1. Optic nerve crush
In contrast to the ﬁndings of RGC body death after optic nerve
transection, the intravitreal preinjection of 3-MA, an inhibitor of
autophagy, resulted in a signiﬁcant delay in axonal degeneration
starting at 90min, which continued until 360 min, after optic nerve
crush compared with controls as evaluated using the axonal
integrity ratio (Kn€oferle et al., 2010). That study also demonstrated
that the application of calcium channel inhibitors signiﬁcantly
delayed the acute phase of axonal degeneration (up to 360 min)
after optic nerve crush and resulted in a signiﬁcant reduction in
LC3-positive autophagosomes at 360 min (Kn€oferle et al., 2010).
Therefore, it is likely that intracellular calcium levels are important
in axonal degeneration in the acute phase after optic nerve crush
with the involvement of autophagic machinery. Although it is un-
clear why rapamycin is protective for RGCs (Rodríguez-Muela et al.,
2012) whereas 3-MA is protective for axons (Kn€oferle et al., 2010),
the main difference between those two studies was that the esti-
mated time after injury was 10 days in the former and a few hours
in the latter. Other differences were the injury type, i.e., transection
or crush, but these injuries are very similar. In addition, theFig. 1. Subcellular localization of p62 and mitochondria in nonstarved and starved RGC-5 ce
(A) and starved (B) RGC-5 cells. Scale bar ¼ 25 mm. Figure modiﬁed from Kitaoka et al. (20methodology for estimating RGC death was immunohistochem-
istry and that for axonal degeneration was in vivo imaging. These
differences may be associated with the opposing ﬁndings.
3.2. Ocular hypertension
Consistent with the ﬁndings of increased autophagosomes in
RGCs in hypertensive glaucoma models (Park et al., 2012; Deng
et al., 2013), our transmission electron microscopic study also
showed noticeable autophagic vacuoles in axons in the hyperten-
sive glaucoma rat model (Fig. 2B). Numerous normal mitochondria
were observed inside axons of the laminar portion in the control
group (Fig. 2A). On the other hand, abnormal mitochondria and
autophagic vacuoles were observed in unmyelinated axons of the
laminar portion 3 weeks after IOP elevation (Fig. 2B). At higher
magniﬁcation, degenerative changes such as neuroﬁlament accu-
mulation were observed in the experimental glaucoma groups in
the myelinated portion (Fig. 2C). Autophagic vacuoles were
observed in the glaucoma (Fig. 2D) and glaucoma þ rapamycin
groups (Fig. 2E, F). In spite of the appearance of autophagic vacuoles
in these groups, degenerative changes were only noted in the
glaucoma group (Fig. 2C, D). In the glaucoma þ rapamycin group
(Fig. 2E, F), myelin andmicrotubule structures were well preserved,
and no apparent degenerative changes were seen. We also found
signiﬁcant increases in LC3-II and p62 levels in optic nerves after
IOP elevation (Kitaoka et al., 2013). As mentioned above, an in-
crease in the amount of LC3-II shown by immunoblotting indicates
either autophagy induction or the suppression of a downstream
step in autophagy. Since p62 accumulates when autophagy is
inhibited, and decreased levels can be observed when autophagy is
induced (Bjørkøy et al., 2009), the increases in LC3-II and p62 levels
both suggest that autophagic ﬂux impairment may occur in optic
nerve degeneration after IOP elevation.
It was reported that rapamycin, an autophagy inducer that can
upregulate ﬂux, signiﬁcantly ameliorated axonal degeneration after
IOP elevation as evidenced by light microscopic ﬁndings assisted by
computer software morphometric analysis as well as electron
microscopic ﬁndings (Kitaoka et al., 2013). This is not consistent
with the ﬁndings that DAPI-positive cells in the RGC layer were
signiﬁcantly increased by the application of the autophagy inhibi-
tor 3-MA after IOP elevation (Park et al., 2012). One possible
explanation is the different roles of autophagy in axons and cell
bodies. It was suggested that the protective effect of autophagy onlls. p62 was colocalized with Mito-Tracker Red, a marker of mitochondria in nonstarved
13).
Fig. 2. Electron microscopic ﬁndings 3 weeks after IOP elevation. The laminar portions of the control (A) and experimental glaucoma (B) groups are shown. Abnormal mitochondria
(black arrowheads) and autophagic vacuoles (black arrows) were noted in unmyelinated axons in experimental glaucoma (B). The myelinated portions in the experimental
glaucoma (C, D) and glaucoma þ rapamycin (E, F) groups are shown. Degenerative changes such as neuroﬁlament accumulation (white asterisk) were noted in experimental
glaucoma (C). The formation of multilamellar bodies is characteristic of autophagic vacuoles (white arrows, C, D). Preserved myelin and microtubule structures were noted in the
glaucoma þ rapamycin (E, F) groups. Autophagic vacuoles (white arrowheads) were observed in the glaucoma (D) and glaucoma þ rapamycin (E, F) groups. Scale bar ¼ 1 mm (A, B)
and 200 nm (CeF). Figure modiﬁed from Kitaoka et al. (2013).
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with the progressive increase in IOP, autophagy is predominantly
activated in the cytoplasm in RGC bodies where it induces cell
death (Lin and Kuang, 2014). However, a pattern of localized retinal
nerve ﬁber layer defects in glaucoma patients indicates that axonal
degeneration may precede RGC body death in this condition, sug-
gesting that successful axonal protection can prevent further
sequential RGC body death. Since we also found that rapamycin
increased LC3-II levels more than IOP elevation alone, and that
increased p62 levels induced by IOP elevation were signiﬁcantly
inhibited by rapamycin in the optic nerve (Kitaoka et al., 2013), it is
likely that autophagic ﬂux impairment in the optic nerve after IOP
elevationmay be improved by rapamycin, thereby leading to axonal
protection. In other areas of the central nervous system, it is also
interesting to note a recent study demonstrating that there are two
mechanisms of the neuroprotective effect of rapamycin: the ﬁrst is
stimulation of autophagy leading to impaired mitochondria
removal; and the second is enhancement of mitochondrial ﬁssion
to allow their elimination by mitophagy in axotomized precer-
ebellar neurons (Cavallucci et al., 2014). Moreover, it has recentlybeen proposed that enhancedmitochondrial function can attenuate
the progression of glaucoma and other neurodegenerative diseases
(Osborne et al., 2014). Taken together, the results indicate that the
modulation of autophagic ﬂux could be a target for the treatment of
neurodegenerative diseases including glaucoma.
3.3. TNF-induced optic nerve damage
3.3.1. TNF-induced axonal degeneration and TNF has been
implicated in Alzheimer's disease
A crucial role of TNF has been suggested in glaucomatous optic
neuropathy (Yan et al., 2000; Yuan and Neufeld, 2000; Tezel et al.,
2001). It was demonstrated that the glial production of TNF is
increased and its death receptor is upregulated on RGCs and optic
nerve axons in glaucomatous eyes (Tezel, 2008). Not only the direct
neurotoxicity of TNF to RGCs and their axons but also its indirect
secondary neurodegeneration along with other cellular events may
contribute to glaucomatous optic neuropathy (Tezel, 2008). A
previous study of proteomic data from human glaucoma showed a
prominent upregulation of TNF/TNF receptor 1 signaling in the
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was shown to cause primary optic nerve axonal degeneration with
subsequent slow RGC body death in rats and mice (Kitaoka et al.,
2006; Nakazawa et al., 2006). In the degenerating optic nerve,
CREB phosphorylation was found to be associated with axonal
protection (Fujino et al., 2009). In the neonatal rat ischemic brain,
rapamycin provided neuroprotection with CREB phosphorylation
(Carloni et al., 2010). On the other hand, previous studies suggested
that glaucoma may be correlated with Alzheimer's disease (AD)
(Tamura et al., 2006; Wostyn et al., 2010). TNF is synthesized and
released from astrocytes and microglia in the central nervous sys-
tem and has been implicated in the pathogenesis and progression
of AD (Paganelli et al., 2002; Alvarez et al., 2007). It was shown that
presenilin is one of the proteases of g-secretase, consisting of
presenilins (PS1 and PS2), nicastrin, Aph-1, and Pen-2, and is
responsible for g-secretase activity, and that the inhibition of PS1
activity is a potential target for antiamyloidogenic therapy in AD
(De Strooper et al., 1998). In addition, it was reported that increased
expression of PS1 is sufﬁcient to increase g-secretase activity (Li
et al., 2011). Our previous study demonstrated that the increase
in p-PS1 and activation of g-secretase in the optic nerve may be
associated with TNF-induced axonal degeneration (Kojima et al.,
2012).3.3.2. Autophagy in AD informs autophagic events in axons
Autophagic impairment was found to stimulate PS1 expression
and g-secretase activation in human embryonic kidney cells (Ohta
et al., 2010). Rapamycin efﬁciently suppressed amyloid-b peptide-
induced neurite degeneration in PC12 cells (Yang et al.,
2014a,b,c). Moreover, rapamycin prevented the synaptic failure
induced by Ab oligomers in rat hippocampal neurons (Ramírez
et al., 2014). It was proposed that impaired autophagy can induce
the accumulation of dysfunctional mitochondria and cause distur-
bances in the processing of amyloid precursor protein (APP) and the
clearance of tau proteins (Salminen et al., 2013). Thus, the
improvement of autophagy seems to be beneﬁcial in treating these
neurodegenerative processes. Our recent study has demonstrated
that rapamycin substantially protects axons in TNF-induced optic
nerve degeneration (Kojima et al., 2014). In APP/PS1 transgenic
mice, there was a signiﬁcant increase in p62 protein levels
compared with wild-type mice without any change in mRNA,
implying that autophagic clearance of p62 is impaired in AD model
neurons (Joshi et al., 2014). The level of p62 is signiﬁcantly
increased in the brain of AD patients relative to controls (Odagiri
et al., 2012). However, it does not appear that upregulated p62 is
speciﬁc to AD pathological processes, since autophagic deﬁciency
caused accumulation of p62 aggregates, but the aggregates did not
contain Ab in the AD model brain (Nilsson et al., 2014). In the optic
nerve, p62 was upregulated after TNF injection, and the inhibition
of p62 by siRNA exerted axonal protection in TNF-induced optic
degeneration (Kojima et al., 2014). Therefore, we propose two
possibilities: ﬁrst, p62 itself may act as a neurodegenerative
candidate since the overexpression of p62 promotes apoptosis with
the activation of caspase-8, while knockdown of p62 reduces hu-
man glioma cell death (Zhang et al., 2013). The forced expression of
p62 consistently decreased the number of neuronal cells under
hypoxic stress (Tanabe et al., 2011). Second, p62 siRNA may affect
autophagic activity, because a recent study has demonstrated that
p62 siRNA activated autophagic machinery as conﬁrmed by in-
creases in lysosome-associated membrane protein 1, LC3-II, and
beclin 1 and by the formation of autophagosomes (Islam et al.,
2014). Thus, p62 appears to have distinct roles depending on the
physiological or pathological condition or the status of proteasome
activity. Nonetheless, modulation of p62 protein levels includingmodulation of autophagy conditions may be an attractive approach
for the treatment of neurodegenerative diseases.
3.4. Nmnat and axonal protection
Several studies suggested that nicotinamide mononucleotide
adenylyltransferase 1 (Nmnat1), an enzyme predominantly located
in the nucleus in the nicotinamide adenine dinucleotide (NAD)
biosynthetic pathway, plays crucial roles in axonal protection
against axotomy in a dorsal root ganglia (DRG) explant culture
(Araki et al., 2004; Wang et al., 2005). Decreased NAD levels were
observed in degenerating axons of cultured neurons (Wang et al.,
2005) and in the spinal cord of experimental autoimmune
encephalomyelitis model mice (Kaneko et al., 2006). Subcellular
localization of Nmnat1, which was shown with cytNmnat1, an
engineered mutant of Nmnat1 localized only to the cytoplasm and
axon, was found to be critical for axonal protection in vivo (Sasaki
et al., 2009). Our previous study found that Nmnat1 is located in
the axoplasm of the optic nerve and that the depletion of Nmnat1
and decreased NAD levels are involved in optic nerve axonal
degeneration (Kitaoka et al., 2009). Other mammalian Nmnat iso-
forms such as Nmnat2 (located in the Golgi apparatus and cytosol)
and Nmnat3 (located in mitochondria) were also reported to exert
axonal protection. For example, the knockdown of endogenous
Nmnat2 caused a signiﬁcant reduction in the percentage of healthy
neurites, and exogenous Nmnat2 protected transected neurites in
superior cervical ganglia (SCG) culture (Gilley and Coleman, 2010).
The regulation of overall cytosolic NADmetabolism by Nmnat2 was
shown to be critical for axon survival (Milde et al., 2013). On the
other hand, overexpression of Nmnat3 provided strong axonal
protection after transection in DRG neurons (Sasaki et al., 2006).
Moreover, overexpression of Nmnat3 was reported to protect
against rotenone-mediated (mitochondrial dysfunction) axonal
degeneration and to delay axonal degeneration induced by treat-
ment with the oxidant H2O2 in DRG neurons (Press and Milbrandt,
2008). Furthermore, transgenic mice overexpressing NMNAT3 had
a signiﬁcant number of preserved axons in injured sciatic nerves,
whereas wild-type mice had mostly degraded axons in injured
nerves (Yahata et al., 2009). Those ﬁndings are consistent with
those of our recent study demonstrating that overexpression of
Nmnat3 exerted a signiﬁcant protective effect against TNF-induced
axonal loss in the optic nerve (Kitaoka et al., 2013). In addition, the
downregulation of Nmnat3 accelerated axonal degeneration
(Fig. 3), implying a pivotal role of endogenous Nmnat3 in certain
conditions in optic nerve degeneration.
Some recent studies have proposed molecular mechanisms of
Nmnat-regulated axonal protection. For example, it was demon-
strated that Highwire ubiquitin ligase, an important regulator of
axonal and synaptic degeneration, is a critical regulator of Nmnat
and may play a central role in regulating the ability of a neuron to
regenerate its connection (Xiong et al., 2012). SkpA functions with
Highwire to regulate axonal stability, and SkpA mutants partially
inhibit axon degeneration, demonstrating a role for SkpA in pro-
moting axonal degeneration after injury (Brace et al., 2014). The
axonal protection seen for SkpA mutants is abrogated upon
knockdown of Nmnat, suggesting that this axonal protection re-
quires Nmnat (Brace et al., 2014). On the other hand, it was
demonstrated that molecular chaperones are key in Nmnat-
regulated axonal protective functions (Rallis et al., 2013). Interest-
ingly, a recent study has proposed a link between Nmnat-mediated
protection and autophagy in dendrite degeneration (Wen et al.,
2013). Our recent study has demonstrated that axonal protection
by Nmnat3 transfection was suppressed by 3-MA in hypertensive
glaucoma model rats (Kitaoka et al., 2013). Taken together with our
observation of substantial autophagic vacuoles in the electron
Fig. 3. Inhibition of Nmnat3 accelerated TNF-induced axon loss. Light microscopic ﬁndings 2 weeks after PBS injection (A), 10-ng TNF injection (B), or 10-ng TNF
injection þ simultaneous injection of 500 pmol of Nmnat3 siRNA (C) (sc-62696, Santa Cruz Biotechnology, Santa Cruz, CA). Scale bar ¼ 10 mm (AeC). (D) Effect of Nmnat3 inhibition
on axon numbers in the optic nerve. Each column represents mean ± SEM; n ¼ 3e5 per group. *p < 0.05. Morphometric analysis of each optic nerve was performed as described
previously with samples from 9 rats (Kitaoka et al., 2011).
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glaucoma, these ﬁndings suggest that the protective effect of
Nmnat3 may be involved in the autophagy machinery in optic
nerve axons after IOP elevation. Nmnat3 transfection decreased
p62 protein levels and increased LC3-II protein levels in the optic
nerve not only in the IOP elevation group, but also in the group
without IOP elevation (Kitaoka et al., 2013). In vitro, substantial
colocalization of Nmnat3 and p62 was observed in nonstarved and
starved RGC-5 cells (Fig. 4). It is particularly important to note that
Nmnat3 transfection increased autophagic ﬂux as shown in the LC3
turnover assay and decreased p62 protein levels in RGC-5 cells
(Kitaoka et al., 2013). In addition, Nmnat3 transfection did not
affect p62mRNA levels in this in vitro system. Therefore, combining
the in vivo and in vitro ﬁndings, it is likely that the protective effect
of Nmnat3 is associated with the autophagy machinery as well as
enhancement of outgoing p62 ﬂux and induction of LC3-II, which
means the enhancement of autophagic ﬂux.
In the NAD biosynthetic pathway, nicotinamide phosphor-
ibosyltransferase (Nampt, an enzyme) converts nicotinamide into
nicotinamide mononucleotide (NMN). Nmnat subsequently con-
verts NMN into NAD. Surprisingly, a very recent study has
demonstrated that blocking Nampt with FK866 added 1 day before
neurite transection potently promoted axonal survival despite
lowering NAD in the SCG culture (Di Stefano et al., 2014). In that
study, treatment with the Nampt inhibitor FK866 was found to
delay axonal degeneration markedly in an in vivo vertebrate
(zebraﬁsh) model organism. Considering the ﬁnding that FK866
induces autophagy in SH-SY5Y neuroblastoma cells (Billington
et al., 2008), it would be particularly interesting to elucidate in
future whether the axonal protection of FK866 is associated with
the autophagy machinery.3.5. ROCK and axonal regeneration
Two Rho-activated serine/threonine kinases have been identi-
ﬁed: ROCK1, which is also known as ROKb and p160ROCK; and
ROCK2, which is also known as ROKa and Rho kinase (Riento and
Ridley, 2003). Many studies reported that the inhibition of ROCK
leads to axonal regeneration of RGCs (Planchamp et al., 2008;
Ahmed et al., 2009). For example, a signiﬁcant increase in the
number of regenerating axons was observed after the addition of
ciliary neurotrophic factor (CNTF) or Y-27632, a ROCK1 inhibitor, to
culture compared with PBS controls in a rat optic nerve crush
model (Lingor et al., 2008). The effect on regeneration was more
pronounced in the optic nerve crush model where animals
administered a combination of Y-27632 and CNTF showed stronger
regeneration compared with CNTF- or Y-27632-alone administra-
tion (Lingor et al., 2008). It was also demonstrated that the neurite
number at the maximum effect of Y-39983, a ROCK1 inhibitor, was
greater than that of Y-27632 in retinal piece culture, and that Y-
39983 exerted substantial regenerative effect after optic nerve
crush (Sagawa et al., 2007).
There is a discrepancy for the role of rapamycin on the axon of
RGC between axonal protection and axonal regeneration. For
example, the mammalian target of rapamycin (mTOR) activity was
suppressed and new protein synthesis was impaired in axotomized
RGCs, which may contribute to the failure to regenerate (Park et al.,
2008). Because rapamycin is an inhibitor of mTOR, it does not
appear beneﬁcial for axonal regeneration. However, we found that
it exerted substantial axonal protection as mentioned above. This
discrepancy suggests that axonal regeneration is not an inevitable
outcome of survival but reﬂects a balance between direct mTOR-
mediated effects on protein synthesis and links to other signaling
Fig. 4. Subcellular localization of p62 and Nmnat3 in nonstarved and starved RGC-5 cells. p62 was colocalized with Nmnat3 in nonstarved (A) and starved (B) RGC-5 cells. Scale
bar ¼ 25 mm. Figure modiﬁed from Kitaoka et al. (2013).
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protection than axonal regeneration (Morgan-Warren et al., 2013).
In this regard, further study pointed out that the inhibition of
autophagy by atg7 siRNA caused the elongation of axons, while
activation of autophagy by rapamycin suppressed axonal growth in
cortical neurons and that autophagy negatively regulated axonal
extension via the RhoA-ROCK pathway (Ban et al., 2013). Unlike
rapamycin, downregulation of ROCK2 promotes axonal regenera-
tion and attenuates axonal degeneration after optic nerve crush and
increases RGC survival after optic nerve axotomy (Koch et al., 2014),
suggesting substantial beneﬁcial roles of the inhibition of ROCK2 in
both neuroprotection and neuroregeneration. Interestingly, it was
shown that the inhibition of ROCK2 resulted in increased LC3-II
levels and decreased p62 levels in RGCs (Koch et al., 2014). That
study using BafA1 also found that ROCK2 downregulation increased
autophagic ﬂux in RGCs. This scenario is consistent with our pre-
vious ﬁndings suggesting that increased autophagic ﬂux leads to
axonal protection (Kitaoka et al., 2013).
4. Aging
4.1. Aging and glaucoma
Several risk factors have been reported for glaucoma develop-
ment, but age is among the strongest andmost consistent. Previous
epidemiological studies, including the Baltimore Eye study (Tielsch
et al., 1991), Beaver Dam Eye study (Klein et al., 1992), Blue
Mountain Eye study (Mitchell et al., 1996), Melbourne Visual
Impairment Project (Wensor et al., 1998), Rotterdam Study (Wolfs
et al., 2000), Los Angeles Latino Eye Study (Jiang et al., 2012), and
Tajimi study (Kawase et al., 2008), showed that age is an important
risk factor for glaucoma development. In Caucasian patients, the
prevalence begins to increase sharply after the age of 60, while in
African-Americans, Asians, and Hispanics, the prevalence begins to
increase at an earlier age, starting at around 40 years.
The impact of cellular senescence on tissue pathophysiology is
still under debate. The accumulation of senescent cells has been
proposed to contribute to the loss of tissue function in aging and
several age-related diseases including glaucoma by different
mechanisms (Fossel, 2002; Campisi, 2005). Senescent cells in the
optic nerve and trabecular meshwork (TM) can disrupt the local
tissue microenvironment via the overexpression of several proin-
ﬂammatory cytokines and production of ROS (Li et al., 2010; Kerntet al., 2013). The increased production of ROS by senescent cells
could potentially lead to an increase in the dysfunction of adjacent
nonsenescent cells and therefore contribute to the development of
glaucoma (Tanito et al., 2012; Feilchenfeld et al., 2008).
In the TM, senescent cells can induce important changes in the
extracellular matrix composition, including the increased expres-
sion and degradation of ﬁbronectin, which leads to the accumula-
tion of degradation products that are believed to have noxious
effects on tissue physiology (Robert and Labat-Robert, 2000; Labat-
Robert and Robert, 2000). The accumulation of such degradation
products in the TM could potentially result in increased outﬂow
resistance and contribute to the development or progression of
glaucoma. Coexistent with age-related increases in the prevalence
of glaucoma is a decrease in the anterior segment outﬂow facility.
That is, the resistance to ﬂuid ﬂow across the TM increases with age
in a linear fashion and begins at a fairly young age (Gabelt and
Kaufman, 2005). This decreased outﬂow facility is largely respon-
sible for the elevated IOP encountered with increasing age. It is
interesting to note that diminished autophagic ﬂux in TM cells has
been suggested to contribute to the pathogenesis of glaucoma
(Porter et al., 2013). However, recent data from human TM cells
have demonstrated that p62 levels are lower in individuals older
than 60 years compared with younger ones (Pulliero et al., 2014).
That study suggested that under physiological conditions, auto-
phagy increases with age in human TM cells due to increased
oxidative stress. Therefore, it is possible that the upregulation of
autophagic ﬂux may be a manifestation of endogenous defensive
mechanisms.
Biochemical factors within the optic nerve head have been re-
ported to play crucial roles in RGC physiology and contribute to the
optic neuropathy of aging and glaucoma (Almasieh et al., 2012). The
posterior sclera of aged monkeys is signiﬁcantly stiffer than that of
younger individuals and leads to axonal damage with the higher
stresses related to IOP elevation (Yang et al., 2014a,b,c). This age-
associated stiffening of the sclera signiﬁcantly inﬂuences the
biomechanical properties of the optic nerve head and may
contribute to age-related susceptibility to glaucomatous optic
damage. Furthermore, damaged phospholipids in mitochondrial
membranes by free radicals due to IOP elevation and aging factor in
the axon can affect membrane integrity, ﬂuidity and trans-
membrane potentials, resulting in RGC degeneration through
decreased Trx2 and subsequent translocation of cytochrome C (cyt
C) and apoptosis inducing factor (AIF) frommitochondria to cytosol
Fig. 5. Axons of 3-month-old SAMR (A), SAMP8 (B), and SAMP10 (C). SAMwas purchased from Japan SLC, Inc (Shizuoka Japan). Scale bar ¼ 20 mm. Axon number of 1- and 3-month-
old SAMR, SAMP8, and SAMP10. Morphometric analysis of each optic nerve was performed as described previously (Kitaoka et al., 2011). Axonal degeneration in 3 month old SAMP8
and SAMP10, compared with that in SAMR (D). Each column represents mean ± SEM; n ¼ 4e6 per group. *p < 0.05.
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also occur in humans andmay be an important underpinning of the
relationship between aging and glaucoma.
4.2. Age-related changes in the optic nerve
The optic nerves of elderly rats display fewer nerve ﬁber proﬁles
with reduced packing density as compared with younger rats. Age-
associated changes are observed especially in the supporting
neuroglial cells, such as oligodendrocytes, astrocytes, and micro-
glia. They are responsible for potassium homeostasis, axoneglial
signaling, and integrity of the nodes of Ranvier and bloodebrain
barrier (Rasband and Shrager, 2000). Oligodendrocytes develop
dense inclusions, some of which occupy swellings of their pro-
cesses. Astrocytes display hypertrophy and contain dense in-
clusions, which may contain phagocytosed myelin material.
Microglia have heterochromatic nuclei and a granular cytoplasm
with inclusions (Yassa, 2014). These changes may contribute to
dysfunctional changes, such as a decline in axonal transport and
axonal loss.
RGC axon number in the optic nerve declines consistently with
age. While methodologic and strain differences or large intra-
sample variability was reported, some studies simply found little
axon loss with age (Repka and Quigley, 1989; Cepurna et al., 2005).
The rate of axon loss per month depends on the total axon number
and is 2.25% of total axons permonth inmice,1.5% of total axons per
month in rats, 0.2% of total axons per month in monkeys, and 0.1%
of total axons per month in humans (Calkins, 2013). These ﬁndings
correspond roughly to life span, so that mammalian species expe-
rience an approximately 40% loss of axons over their lifetime
(Neufeld and Gachie, 2003).
Our laboratory focuses on age-related axonal degeneration and
RGC body death in mice. Because the life spans of rats and mice arenot longer than 24 months, it is difﬁcult to detect signiﬁcant mo-
lecular changes due to cellular senescence in aging mice and rats.
The senescence accelerated mice (SAM) strain was developed from
the AKR/J strain by Kyoto University researchers. The R-series
(SAMR) shows normal aging. In contrast, the P-series (SAMP) ex-
hibits accelerated senescence (Takeda et al., 1997). The early onset
and irreversible advance of senescence manifested by several signs
such as deﬁcits in learning and memory and emotional disorders
are characteristic of SAMP8 and -P10 (Takeda, 2009). Furthermore,
our research showed that greater RGC axon loss occurred in 3-
month-old SAMP8 and -P10 compared with SAMR (Fig. 5). Age-
related pathological changes in RGC axons were observed in mice
at least 12 months old and were more evident in 24-month-old
C57/BL6 mice (Samuel et al., 2011). Since pathological changes in
RGC axons in the SAM strain were more evident and occurred
earlier than those in C57/BL6 and other mice strains, SAM are useful
to analyze biological changes in RGCs due to senescence.
4.3. Age-related change in RGC bodies
Since RGC axons decline proportionally with age as described
above, it could be assumed that a decline occurs in RGC bodies in
the retina. In the monkey retina, however, over a nearly 30-year
lifespan the number of RGC bodies does not change regardless of
eccentricity from the fovea or retinal quadrant (Kim et al., 1996).
Furthermore, over a 2-year life span the number of RGC bodies does
not change in the C57BL/6 mouse retina (Samuel et al., 2011).
However, the dendritic arbors of at least some types of mouse
RGC shrink by approximately 20% with a concomitant decrease in
the density of IPL synapses (Samuel et al., 2011). Another report
(Danias et al., 2003) found age-related RGC body loss in C57 mouse
retinas based on morphological analysis with retrograde Fluoro-
Gold labeling from the superior colliculus. It is not surprising that
Fig. 6. Fluorescence micrograph fromwhole mounted retinas of 3-month-old SAMR (A), SAMP8 (B), and SAMP10 (C). Retrograde labeling of RGCs with Fluoro-Gold (Fluorochrome,
Denver, CO) was performed as described previously (Kitaoka et al., 2009). Scale bar ¼ 20 mm. RGCs density of 1- and 3-month-old SAMR, SAMP8, and SAMP10. RGCs loss in 3-month-
old SAMP8 and SAMP10, compared with that in SAMR (D). Each column represents mean ± SEM; n ¼ 4e6 per group. *p < 0.05.
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with decreased axonal transport of Fluoro-Gold from the superior
colliculus (Danias et al., 2003). A signiﬁcant loss of RGC bodies in
SAMP8 and -P10 was observed at 3 months (Fig. 6). Since RGCs
were labeled with Fluoro-Gold 2 months before the mice were
sacriﬁced, i.e., 1 month after birth, presumably there was no axonal
damage at that time. Our current data indicate that RGC death was
not due to decreased axonal ﬂow. Cresyl violet, which is not speciﬁc
for RGC, stains not only neuronal but also glial cells. Our morpho-
logical study from counting cells in the RGC layer distinguished
neuronal cells from glial cells based on their shape under micro-
scopy. Our cresyl violet staining results conﬁrmed decreased
neuronal cells (RGCs and displaced amacrine cells) in SAMP8 and
-P10 at 3 months (Fig. 7). Although cell body death relies on pre-
dominantly axonal degeneration and decreased axonal ﬂow in
senescence as described above, the RGC body is also susceptible to
various forms of age-related stress.5. Sirt1 in aging
5.1. Biological role of Sirt1
The sirtuins are a highly conserved family of (NADþ)-depen-
dent histone deacetylases that help regulate the life span of
diverse organisms (Koltai et al., 2010). The human genome en-
codes seven different sirtuins (Sirt1e7) that share a commoncatalytic core domain but process distinct N- and C-terminal ex-
tensions (de Oliveira et al., 2010). Of the seven mammalian sirtuin
proteins, Sirt1 has been the most extensively characterized. Sirt1
plays a pivotal role in the antiaging effects of caloric restriction
(CR) (Bonda et al., 2011), the protective effect of CR against
neurodegenerative disease (Chen et al., 2008), and enhancement
of the proliferative state of neuronal stem cells in the rat hippo-
campus (Torres et al., 2011), as well as being involved in protection
against cellular oxidative stress and DNA damage (Gorenne et al.,
2013).
Several important clues about Sirt1 function have emerged from
studies of knockout and transgenic mice. In general, Sirt1 knock-
down or its inhibition results in decreased physical activity due to
reduced secretion of growth hormone (Cohen et al., 2009) and
reduced thyroid-stimulating hormone (Akieda-Asai et al., 2010)
and results in many of molecular changes including induction of
vascular leakage and inﬂammation (Wu et al., 2012).5.2. Sirt1 in axons
The neuroprotective effect of Sirt1 against axonal degeneration
was observed in a study of slow Wallerian degeneration (Wlds)
mutant mice (Perry et al., 1990). Wlds mutant mice exhibit a sig-
niﬁcant delay in the onset of axonal degeneration after physical or
chemical injury (Coleman and Perry, 2002; Coleman, 2005). Axonal
protection byWlds is mediated through overexpression of Nmnat1
Fig. 7. Whole-mounted retinas of 3-month-old SAMR (A), SAMP8 (B), and SAMP10 (C), showing neuronal cells (RGCs and displaced amacrine cells) stained with 1% cresyl violet as
described previously (Kitaoka et al., 2006). Scale bar¼ 20 mm. Neuronal cells numbers of 1- and 3-month-old SAMR, SAMP8, and SAMP10. Neuronal cells loss in 3-month-old SAMP8
and SAMP10, compared with that in SAMR (D). Each column represents mean ± SEM; n ¼ 4e6 per group. *p < 0.05.
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is blocked by the Sirt1 inhibitor sirtinol and by Sirt1 silencing with
siRNA (Araki et al., 2004). It was demonstrated that NADþ treat-
ment protected certain types of axon by suppressing oxidative
stress (Ding et al., 2013). Similarly, it was shown that NADþ treat-
ment protected axons from oxidative stress-induced degeneration
of the spinal cord (Bros et al., 2014). In the eyes, a previous study
indicated that accumulation of superoxide in the optic nerve was
increased in crushed nerves compared with controls. This change
was suppressed by Sirt1 overexpression and resveratrol treatment
(Zuo et al., 2013). More recently, the administration of a sirt1-
activating compound (SRTAW04) signiﬁcantly reduced ROS levels
and preserved axons in the optic nerve in an optic neuritis model
(Khan et al., 2014). Our recent study showed that Sirt1 levels in the
optic nerve of 1-month-old SAMP8 and -P10 mice were decreased
compared with those in controls (Fig. 8). We therefore suspect the
involvement of a Sirt1-dependent process in axonal degeneration
in senescence-accelerated conditions. Our results and those of
previous studies suggest that activation of the Sirt1 pathway may
be a useful strategy for axonal protection via the suppression of
oxidative stress.5.3. Sirt1 in the retina
Sirt1 is distributed in most retinal layers. It is mainly localized in
the nucleus, although it can be translocated to the cytoplasm and
stimulates downstream molecules under various forms of stress.Sirt1 maintains energy homeostasis and antiapoptotic mechanisms
essential for ameliorating the effects of oxidative stress in the
retina. A previous study reported that Sirt1 maintains survival
pathways, balances energy homeostasis, and is involved in a
physiological DNA repair mechanism in photoreceptor cells to treat
inherited retinal degenerative disease (Jaliffa et al., 2009). The
intravitreal injection of SRT647 and SRT501, which are Sirt1 acti-
vators, prevented RGC loss in a dose-dependent manner by stim-
ulating Sirt1 enzymatic activity in a mouse optic neuritis model
(Shindler et al., 2007). Furthermore, the upregulation of Sirt1 by
resveratrol protects cultured retinal cells from antibody-induced
apoptotic death (Anekonda and Adamus, 2008).
Intravitreal injection of resveratrol exerts neuroprotective effect
through sirt1 overexpression following optic nerve crush (Kim
et al., 2013). This effect was diminished by co-injection of sirtinol,
a Sirt1 inhibitor, indicating therapeutic potential of overexpression
of Sirt1 (Kim et al., 2013). The accumulation of superoxide was
reduced in mice overexpressing Sirt1 or treated with resveratrol,
indicating the protective effect of Sirt1 via modulation of oxidative
stress (Zuo et al., 2013). Sirtinol reduced RGC viability in hypoxia
and increased apoptotic markers such as caspase 3 activity and
phosphorylation of c-Jun N-terminal kinase (JNK) (Balaiya et al.,
2012). Our study showed that Sirt1 in isolated RGCs was
decreased in SAMP8 and -P10 compared with SAMR (Fig. 9). These
results are consistent with the data on Sirt1 changes in the optic
nerve of SAM (Fig. 8). A decrease in Sirt1 may contribute to RGC
death through increased susceptibility to oxidative stress.
Fig. 8. Immunoblotting was performed as described previously (Munemasa et al., 2008) using antibodies for Sirt1 (Santa Cruz Biotechnology), LC3 (Medical & Biological Labo-
ratories Co., Nagoya, Japan), p62 (Medical & Biological Laboratories Co), and) b actin (SigmaeAldrich) with optic nerve lysate of 1-and 3-month-old SAMR, SAMP8, and SAMP10 (A
and C). Densitometry of the bands was analyzed with NIH Image software (National Institutes of Health, Bethesda, MD) (B and D). Signiﬁcant decreases in Sirt1 in 1- and 3-month-
old SAMP8 and SAMP10, compared with that in SAMR. Signiﬁcant increases in LC3-II in 1- and 3-month-old SAMP8 and SAMP10, compared with that in SAMR (B and D). Each
column represents mean ± SEM.; n ¼ 4 per group. *p < 0.05.
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6.1. Autophagy in cellular senescence
The inhibition of autophagy induces neurodegenerative changes
in mammalian neuronal tissues which resemble those associated
with aging, and pathological aging is often associated with a
reduction in the number of autophagic-related molecules (Fields
et al., 2013; He et al., 2013). Several reports indicated that Atg
proteins or other proteins required for autophagy induction have
reduced expression in aged tissues and that autophagy diminishes
with aging (Yang et al., 2014a,b,c). This ﬁnding, for example, wasobserved in normal human brain aging with downregulated Atg5,
Atg7, and Beclin1 (Bec-1). Likewise, inositol trisphosphate receptor
signaling is increased in age-related neurodegenerative diseases
such as AD, suggesting a possible decrease in autophagy in these
conditions (Lipinski et al., 2010; Decuypere et al., 2011). Although
merely phenomenological and correlative, the cumulative ﬁndings
suggest that the exhaustion of the autophagic response may
contribute to the aging phenotype.
Loss-of-function mutations in Atg1, Atg7, Atg18, and Bec-1 re-
sults in damaged cytoplasmic constituents accumulating in all ag-
ing cells and the levels of those constituents subsequently showed
decreased during the life span of the nematode Caenorhabditis
Fig. 9. Immunoblotting for Sirt1 with isolated RGCs of 1-month-old SAMR, SAMP8,
and SAMP10 (A). RGC isolation was carried out with magnetic beads as described
previously (Munemasa et al., 2008). (B) Signiﬁcant decrease in Sirt1 of SAMP8 and
SAMP10, compared with that in SAMR. Each column represents mean ± SEM; n ¼ 3 per
group. *p < 0.05.
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Sestrin, another autophagy-related molecule, reduces the life span
of the fruit ﬂy Drosophila melanogaster (Lee et al., 2010; Simonsen
et al., 2008). This is related to age-associated pathologies,
including triglyceride accumulation, mitochondrial dysfunction,
muscle degeneration, and cardiac malfunction (Lee et al., 2010).
Although autophagy is indispensable for mobilizing intracel-
lular energy reserves during the transition from intrauterine
metabolism to weaning, the knockout of Atg proteins is lethal
during the early postnatal period (Levine and Kroemer, 2008).
Conditional knockout of Atg genes has age-related phenotypes and
precipitates the manifestation of multiple age-associated stigmata,Fig. 10. Schematic diagram of the relationship between Sirt1 and autophagy in aging.
A decrease in Sirt1 inﬂuences autophagy activation and autophagic ﬂux impairment.including the accumulation of intracellular inclusion bodies con-
taining ubiquitinylated proteins and lysosomes containing the ag-
ing pigment lipofuscin, dysfunctional mitochondria, and the
oxidation of proteins related to their carbonylation (Komatsu et al.,
2006; Hara et al., 2006). Thus normal aging may be associated with
insufﬁcient autophagy, which can explain at least part of the aging
phenotype.
CR, i.e., reduced food intake without malnutrition, is the pivotal
antiaging intervention that extends the life span of most animals
tested so far, including rhesus monkeys, in which it reduces the
incidence of diabetes, cardiovascular disease, cancer, and brain at-
rophy (Colman et al., 2009). CR is the most physiological inducer of
autophagy (Levine and Kroemer, 2008), and inhibition of auto-
phagy prevents the antiaging effect of CR in all species investigated
in this respect.
6.2. Autophagy and SAM
A previous study showed increased LC3-II in the hippocampal
neurons of 7-month-old SAMP8, similar to pathological changes
seen in late-onset AD (Ma et al., 2011). In our study, increased LC3-II
levels were also noted in the optic nerve of 1-month-old SAMP8
and -P10 (Fig. 8) compared with SAMR. On the other hand, there
were no signiﬁcant changes in p62 levels among 1-month-old
SAMR, -P8, and -P10 (Fig. 8). Since axonal degeneration was not
seen in 1-month old SAMP8 and -P10 in our morphological ex-
amination (Fig. 5), one hypothesis is that the increased LC3-II level
was due to an endogenous protective reaction rather than auto-
phagy ﬂux impairment. Another possibility is that the unchanged
p62 levels are a manifestation of the transition status from ﬂux
activation to ﬂux impairment. At 3 months, p62 was accumulated
in SAMP8 and -P10, implying that lysosomal dysfunction may occur
with subsequent autophagic ﬂux impairment, thereby leading to
axonal degeneration during the aging process in the optic nerve
(Fig. 8). The accumulation of p62 was seen in the hippocampus, and
the dysregulation of autophagy may affect the turnover of
aggregate-prone proteins in aged mice (Soontornniyomkij et al.,
2012).
6.3. Autophagy and Sirt1
Autophagy and senescence share a number of characteristics,
which suggests that both responses could serve to protect cells
collaterally from the toxicity of external stress such as oxidative
ROS and mitochondrial apoptotic factor (Ou et al., 2014). Recent
studies have shown that autophagy regulates Sirt1, a key molecule
in aging, in cellular senescence. Sirt1 could inﬂuence autophagy
directly via its deacetylation of key components of the autophagy
induction pathway, such as the products of autophagy genes Atg 5,
7, and 8 (Suzuki and Bartlett, 2014).
The link between Sirt1 and autophagy is supported by multiple
ﬁndings. Resveratrol, a recognized Sirt1 activator, induces the
activation of autophagy, and it has been shown that this occurs in
a sirt1-dependent manner (Morselli et al., 2011). It was noted that
resveratrol could suppress autophagy via the inhibition of S6 ki-
nase (Hwang et al., 2010). Sirtinol, a classic inhibitor of Sirt1, also
increases autophagy based on the elevation of LC3-II levels and
autophagic cell death in MCF-7 cells (Wang et al., 2013). These
observations indicate that Sirt1 modulates Atg proteins and sub-
sequently activates autophagy machinery. Another possible sce-
nario is represented by weak correlations within an experimental
system in which autophagy and Sirt1 are simultaneously acti-
vated. The diterpenoid oridonin inhibits the proliferation of both
Hela (Cui et al., 2006) and the multiple myeloma (MM) cell line
RPMI 8266 (Zeng et al., 2012a). In both cell lines, autophagy and
Fig. 11. Schematic diagram of autophagic ﬂux status and mitochondrial movement inside optic nerve axons.
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decreased in the MM cell line. Furthermore, the Sirt1 level
increased in the latter cell line by another type of autophagy in-
duction, nutrient depletion (Zeng et al., 2012b). The inhibition of
autophagy by 3-MA suppressed Sirt1 expression in all these cases.
In contrast, autophagy induced by Sirt1 activation plays a pivotal
role in protecting against prion-induced neuronal cell death
(Jeong et al., 2013). That study also suggested that regulating
autophagy including that by Sirt1 activation may be a therapeutic
target for neurodegenerative disorders including prion disease.
We found that although LC3-II was increased in the optic nerve
of 1-month-old SAMP8 and -P10, Sirt1 was decreased. This appears
to contradict the results of previous studies showing that Sirt1
activity could conceivably inﬂuence autophagy activation. Howev-
er, considering the p62 ﬁndings, decreased Sirt1 in the optic nerve
precedes autophagic ﬂux impairment, because thereafter increases
in p62 levels were observed in 3-month-old SAMP8 and -P10,
which may result in cellular senescence and age-related patho-
logical changes (Fig. 10). Therefore, enhancement of the clearance
of short-lived ubiquitin-proteasome system-speciﬁc substrates by
Sirt1-modulated autophagy may have beneﬁcial effects on age-
related neurodegeneration.
6.4. Autophagy and other age-related neurodegenerative diseases
Signiﬁcant accumulation of damaged protein, lipids, and DNA
has been found in Parkinson's disease, indicating an insufﬁcient
clearance of these modiﬁed molecules. Genetic ablation of auto-
phagy genes Atg5 and Atg7 has been shown to cause abnormal
accumulation of cytoplasmic inclusion bodies (Hara et al., 2006;
Komatsu et al., 2006). Mouse brains or primary neurons with de-
ﬁciencies in Parkin, PINK1, and DJ-1, which can be regulated by the
mitochondrial autophagy machinery, exhibited mitochondrial ab-
normalities that may be due to insufﬁcient mitophagy (Mortiboys
et al., 2008; Wang et al., 2011), increased protein oxidation, and
lipid peroxidation (Palacino et al., 2004), increased mitochondrial
or cytosolic ROS and mito-roGFP oxidation (Gandhi et al., 2009),
and increased sensitivity to neurotoxic or inﬂammatory insults
(Manning-Bog et al., 2007).
Animal studies in neurodegenerative diseases with modulation
of autophagy have shown positive results. Rapamaycin and treha-
losedecreasedprotein aggregation in animalmodels of amyotrophic
lateral sclerosis, Huntington's disease, AD, and Parkinson's disease
(Rodríguez-Navarro et al., 2010; Castillo et al., 2013; Ozcelik et al.,
2013). Although it is hypothesized that autophagy activation de-
creases thewidespreadpropagationof oxidativedamage inneurons,
many studies focused on demonstrating decreased accumulation ofharmful proteins and cell death without directly examining the
cellular redox status or oxidative damage. Future mechanistic in-
vestigations of the effects of autophagy upregulation on the oxida-
tive damage of proteins, lipids, DNA, or organelles in animal models
of neurodegenerative disease are therefore necessary.
7. Conclusions and future directions
The molecular mechanism of RGC death and axonal degenera-
tion in glaucoma has been investigated in several laboratories. A
recent study that used induced pluripotent stem cells (iPSCs)
generated from dermal ﬁbroblasts obtained from a patients with
TANK binding kinase 1 (TBK1)-associated normal tension glaucoma
showed that there was an increase in LC3-II expression in iPSC-
derived RGCs from an NTG patient with a TBK1 gene duplication
compared with those from unrelated control subjects that do not
have a diagnosis of glaucoma (Tucker et al., 2014), implicating an
important role for this cellular process in the human glaucoma.
Although the involvement of autophagy has recently been
demonstrated in RGC body death, its role in axonal degeneration
has not been elucidated thoroughly. Autophagy is a dynamic pro-
cess, and it is important to comprehend the autophagic ﬂux status
in each pathological condition. As shown Fig. 11, an increase in
autophagosome number can be seen in both the activation of
autophagy and blockade of autophagosomal degradation. In addi-
tion to these dynamic states, in optic nerve axons, the condition of
axonal ﬂow may also affect the number of autophagosomes.
Mitochondria are also moving, and their function and behavior may
affect autophagic ﬂux. If one could determine the increase in
autophagosomes (i.e., LC3-II) as “autophagy” at a speciﬁc point,
then “autophagy” means impaired or induced, and therefore both
opposing ﬁndings could be observed. However, if one could
determine ﬂux, then more accurate molecular mechanisms could
be investigated. Because enhanced autophagy ﬂux leads to
increasing clearance of unnecessary proteins and damaged mito-
chondria, it may be part of the neuronal survival pathway. Thus, the
modulation of autophagy ﬂux may be a potential target for neu-
roprotective interventions in glaucomatous optic neuropathy.
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